Clinical trial Recruiting at 1 site Interventional Ages 6 to 12

Improving learning of a cough assistance technique in children

Official title: Does the Coaching Function Improve the Learning of Mechanical In-exsufflation (MI-E) in Paediatric Subjects?

Run by Cliniques universitaires Saint-Luc- Université Catholique de Louvain · NCT06190431 · Data updated 2026-11-12

This study is testing if a fun coaching program can help children, both healthy and those with neuromuscular diseases, learn a special cough technique better than just regular guidance from a physiotherapist.

Quick facts

Study typeInterventional
Ages6 Years to 12 Years
SexAll
Enrollment40 (estimated)
SponsorCliniques universitaires Saint-Luc- Université Catholique de Louvain
Academic / other
Locations1 site (Brussels, Brussels Capital)
StatusRecruiting
StartedNovember 20, 2023
Main results expectedJanuary 20, 2024
Study endsMay 31, 2026
Registry record updatedJune 1, 2026
Trial IDNCT06190431 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 6 to 12 who can understand French and have either no significant health issues or have a neuromuscular disease.

Probably not a fit

Patients with hemodynamic instability, recent pneumothorax, or hemoptysis may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate whether a coaching module using playful visual stimulation can enhance the learning and effectiveness of the mechanical insufflation-exsufflation (MI-E) technique in children. The trial will be conducted in two phases: the first will involve healthy children aged 6 to 12, while the second will focus on children with neuromuscular diseases. Participants will be randomly assigned to receive either physiotherapist guidance alone or guidance combined with the coaching module. The goal is to determine if the coaching module leads to better learning outcomes and compliance with the MI-E technique.

Why it matters

Potential benefit: If successful, this approach could significantly improve airway clearance techniques in pediatric patients, enhancing their respiratory health.

How similar studies have gone: While the use of MI-E is well-documented, the specific approach of using a coaching module in this context is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Part 1:

* Inclusion criteria

  * Age 6-12 (F/M)
  * Acceptance of consent (child + 2 parents)
  * Non-smoker
  * Speak and understand French
  * Schooling in mainstream education
* Exclusion criteria

  * Comorbidities: congenital heart disease, chronic lung disease, immune deficiency, neuromuscular disease, neurological disease or multiple disabilities
  * History or clinical signs of disease affecting lung function, recent lung infection, spinal or thoracic deformity.

Part 2:

* Inclusion criteria

  * Age 6-12 (F/M)
  * Acceptance of consent (child + 2 parents)
  * Non-smoker
  * Speak and understand French
  * Patient with a neuromuscular disease
  * Able to perform the MI-E maneuver
* Exclusion criteria

  * Hemodynamic instability
  * Current or recent pneumothorax
  * Hemoptysis

Where it's running

  • Cliniques universitaires Saint Luc
    Brussels, Brussels Capital, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.